Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season —

by
from Morbidity and Mortality Weekly Report (MMWR) on (#6K5XQ)
This report describes effectiveness of nirsevimab against respiratory syncytial virus-associated hospitalizations in infants.
External Content
Source RSS or Atom Feed
Feed Location http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Feed Title Morbidity and Mortality Weekly Report (MMWR)
Feed Link https://www.cdc.gov/mmwr/index.html
Reply 0 comments